Share prices for Follicum (FOLLI)

Price information




Scheduled Reports

Interim Report Q1

Annual General Meeting

Half Year Report

Interim Report Q3

Year End Report

About company

Follicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, the drug candidate FOL-014 has demonstrated an increase in insulin release in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Aktietorget since 2014.

  • CEO Jan Alenfall
  • Chairm. of the Board Fredrik Buch

Instrument Information

  • Full Name Follicum
  • Short Name FOLLI
  • No of shares 28 121 566
  • ISIN code SE0006288270
  • OrderBookID 412P
  • CFI (ISO 10962) ESVUFR
  • Liquidity Provider Sedermera Fondkommission
  • Par Value 0.12 kr
  • First Traded 25-11-2014
  • Type Share